Genomic features of AML in patients over age 60 can predict success of stem cell transplant

(Dana-Farber Cancer Institute) For older patients with AML, the prospects for success of a stem cell transplant can often be predicted based on the particular set of genetic mutations within the tumor cells, investigators at Dana-Farber Cancer Institute will report at the ASH Annual Meeting.